Pacific Biosciences of California Inc (NASDAQ: PACB) kicked off on Friday, down -4.90% from the previous trading day, before settling in for the closing price of $2.04. Over the past 52 weeks, PACB has traded in a range of $0.85-$2.72.
Healthcare Sector giant saw their annual sales slid by -23.55% over the last five years. While this was happening, its average annual earnings per share was recorded -64.82%. With a float of $270.83 million, this company’s outstanding shares have now reached $301.85 million.
Pacific Biosciences of California Inc (PACB) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Pacific Biosciences of California Inc is 10.29%, while institutional ownership is 52.58%. The most recent insider transaction that took place on Aug 18 ’25, was worth 35,182. In this transaction an insider of this company sold 26,836 shares at a rate of $1.31, taking the stock ownership to the 1,920,035 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Officer proposed sale 26,836 for $1.31, making the entire transaction worth $35,174.
Pacific Biosciences of California Inc (PACB) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.2 earnings per share (EPS), lower than consensus estimate (set at -0.17) by -0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -64.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.39% during the next five years compared to -23.55% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
Take a look at Pacific Biosciences of California Inc’s (PACB) current performance indicators. Last quarter, stock had a quick ratio of 5.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.18, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.52 in one year’s time.
